The length of life of rhabdomyosarcoma is mainly related to many factors such as the severity of the disease, the risk level of the tumor, the treatment and the individual factors of the patient, which should be analyzed on a case-by-case basis and should not be generalized. Generally speaking, early stage rhabdomyosarcoma, through standard surgery and perioperative treatment, has a better prognosis, and some patients can be completely cured and survive for a long time. If the patient is in the middle or late stage when the disease is discovered, has a high tumor risk classification, or has recurrence of metastasis after treatment, the prognosis is poorer, and the survival rate over 5 years usually does not exceed 60%. Therefore, patients with rhabdomyosarcoma should promptly visit the medical oncology department of regular hospitals for examination, and after clarifying the specific condition, actively cooperate with doctors for targeted treatment. At the same time, it is also crucial to regulate one’s mentality during the treatment process, which is conducive to prolonging the survival period.